This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Josai University Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Kenji Mori: Innovator in Immunosuppressive Antibodies
Introduction
Kenji Mori is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of immunology through his innovative research and development of monoclonal antibodies.
Latest Patents
Kenji Mori holds a patent for a monoclonal antibody having immunosuppressive activity or an antigen binding fragment thereof. This invention relates to a monoclonal antibody that exhibits excellent immunosuppressive activity. More specifically, it binds to a peptide consisting of an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO: 1) or a conjugate of the peptide and a pharmaceutically acceptable carrier. The monoclonal antibody or its antigen binding fragment demonstrates a higher binding affinity for core histone than for histone H1. He has 1 patent to his name.
Career Highlights
Kenji Mori is affiliated with Josai University Corporation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Kenji has collaborated with notable colleagues in his field, including Shuji Sato and Takeshi Goto. Their combined expertise contributes to the innovative research environment at Josai University Corporation.
Conclusion
Kenji Mori's contributions to the development of immunosuppressive antibodies highlight his role as a significant inventor in the field of immunology. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile